Your browser doesn't support javascript.
loading
The reperfusion rates after recombinant human tissue plasminogen activator thrombolysis depend not on a few but on a plethora of influencing factors.
Finsterer, Josef; Scorza, Fulvio Alexandre; Scorza, Carla Alexandra.
Affiliation
  • Finsterer J; Neurology and Neurophysiology Center, Department of Neurology - Vienna, Austria.
  • Scorza FA; Universidade Federal de São Paulo/Escola Paulista de Medicina, Neuroscience Discipline - São Paulo (SP), Brazil.
  • Scorza CA; Universidade Federal de São Paulo/Escola Paulista de Medicina, Neuroscience Discipline - São Paulo (SP), Brazil.
Rev Assoc Med Bras (1992) ; 70(5): e20240103, 2024.
Article in En | MEDLINE | ID: mdl-38775518
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Tissue Plasminogen Activator / Fibrinolytic Agents Limits: Humans Language: En Journal: Rev Assoc Med Bras (1992) Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Tissue Plasminogen Activator / Fibrinolytic Agents Limits: Humans Language: En Journal: Rev Assoc Med Bras (1992) Year: 2024 Document type: Article